Suzhou Alphamab Co., Ltd.

This study tests a new medicine called KN057 to see if it can prevent bleeding episodes in people with hemophilia A or B who have developed inhibitors (antibodies that block standard treatment). About 53 men aged 12 to 70 will take part. Some will get KN057 regularly for a year, …

This study tests a new drug called KN057 to see if it can prevent bleeding episodes in people with hemophilia A or B who do not have inhibitors. About 125 male participants aged 12 to 70 will receive either KN057 or standard care for up to 52 weeks. The goal is to reduce the numb…

This study tested a new drug called KN060 against a standard blood thinner (enoxaparin) to see which works better at preventing dangerous blood clots after total knee replacement surgery. About 241 adults aged 18 to 75 who were having knee replacement took part. The goal was to c…